Combination Therapy with Pioglitazone/Exenatide Metformin Reduces the Prevalence of Hepatic Fibrosis and Steatosis: The Efficacy and Durability of Initial Combination Therapy for Type 2 Diabetes (
EDICT
) Trial
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
2011 ◽
Vol 13
(7)
◽
pp. 653-661
◽
2004 ◽
Vol 20
(6)
◽
pp. 883-889
◽
Keyword(s):
Keyword(s):
2014 ◽
Vol 16
(7)
◽
pp. 613-621
◽
2010 ◽
Vol 12
(5)
◽
pp. 442-451
◽